Chemotherapy and Radiation in Treating Patients With Stage 3 Non-Small Cell Lung Cancer (PROCLAIM)
Study Status
Open to Enrollment
Study Description
This study will compare the overall survival of patients with locally advanced, Stage III Non-Small Cell Lung Cancer with nonsquamous cell histology.
This study has two arms:
- Arm A (Experimental Interventions): Pemetrexed, Cisplatin, Thoracic Radiation Therapy
- Arm B (Active Comparator Intervention): Etoposide, Cisplatin, Vinorelbine. Paclitaxel, Carboplatin. Thoracic Radiation Therapy
Disease Status and/or Stage
Unresectable, Locally Advance, Stage III Non-Small Cell Lung Cancer
Sponsor
Eli Lily & Co.
Key Eligibility
- Men and women, age 18 and older
- Stage 3A or 3B Non-Small Cell Lung Cancer of the non-squamous type
- Measurable tumor lesions
- Additional eligibility discussed when you contact the study team
Principal Investigator
Contact
- Gina Mileo
- 212-746-5430
Healthy Volunteers
As a healthy volunteer in a clinical trial you may make a significant contribution to the discovery of medical knowledge and new treatments that could impact people around the world.
Click here for studies seeking healthy volunteers.
Contact Us
For general inquiries, or if you need assistance finding a study, please contact:
Erica Bersin
Tel: (646) 962-8232
[email protected]
